18 Dec 2025 · New Hampshire
HB1809 introduced
Authorizing the medical use of psilocybin through a program established in the department of health and human services.
17 Dec 2025 · New Hampshire
HB1796 introduced
Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.
4 Nov 2025 · Florida
H0309 introduced
Controlled Substances
10 Oct 2025 · California
AB1103 signed into law
Controlled substances: research.
9 Sep 2025 · California
AB1103 passed legislature
Controlled substances: research.
1 Jul 2025 · Iowa
SF659 took effect
Appropriations act including crystalline polymorph psilocybin provisions
27 Jun 2025 · Oregon
SB844 passed legislature
Relating to public health
25 Jun 2025 · Michigan
HB4686 introduced
Crimes: controlled substances; creating, manufacturing, possessing, or using psilocybin or psilocin; allow under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7404a.
11 Jun 2025 · Iowa
HF383 vetoed
A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (Formerly HF 14.) Vetoed 6-11-25.
11 Jun 2025 · Iowa
SF659 signed into law
Appropriations act including crystalline polymorph psilocybin provisions
11 Jun 2025 · Texas
SB2308 signed into law
Relating to the establishment of a consortium to conduct FDA drug development clinical trials with ibogaine
11 Jun 2025 · Texas
SB2308 took effect
Relating to the establishment of a consortium to conduct FDA drug development clinical trials with ibogaine
3 Jun 2025 · Maine
LD1034 passed legislature
An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults
1 Jun 2025 · Texas
SB2308 passed legislature
Relating to the establishment of a consortium to conduct FDA drug development clinical trials with ibogaine
19 May 2025 · Iowa
HF383 passed legislature
A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (Formerly HF 14.) Vetoed 6-11-25.
14 May 2025 · Iowa
SSB1241 introduced
A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers, authorizing expenditure of unappropriated moneys in special funds, providing for properly related matters including crystalline polymorph psilocybin and medical residency and fellowship positions, making corrections, and including effective date and retroactive applicability provisions.(See SF 659.)
14 May 2025 · Iowa
SF659 introduced
Appropriations act including crystalline polymorph psilocybin provisions
14 May 2025 · Iowa
SF659 passed legislature
Appropriations act including crystalline polymorph psilocybin provisions
12 May 2025 · Pennsylvania
HB1439 introduced
Amending The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control — Still pending as of Oct 21, 2026: in House Health since May 12, 2025.
22 Apr 2025 · Massachusetts
H4050 introduced
To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof
7 Apr 2025 · New Mexico
SB219 signed into law
Medical Psilocybin Act
27 Mar 2025 · Iowa
HF978 introduced
A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)
27 Mar 2025 · Massachusetts
H4200 introduced
An Act authorizing a pilot for the use of psychedelics in licensed treatment facilities — Still pending as of Oct 21, 2026: reported favourably and sent to House Ways and Means on July 23, 2026.
27 Mar 2025 · Minnesota
HF2906 introduced
Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.
26 Mar 2025 · Colorado
HB1063 passed legislature
FDA-Approved Crystalline Polymorph Psilocybin Use
25 Mar 2025 · North Carolina
S568 introduced
Innovative Treatments for Mental Health Act
24 Mar 2025 · Minnesota
HF2699 introduced
Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated.
24 Mar 2025 · Virginia
SB1135 vetoed
Crystalline polymorph psilocybin; regulations for prescribing, etc.
19 Mar 2025 · North Dakota
SB2064 passed legislature
Relating to the scheduling of controlled substances — Enacted; filed with the Secretary of State on March 26, 2025.
18 Mar 2025 · New Mexico
SB219 passed legislature
Medical Psilocybin Act
14 Mar 2025 · New Mexico
HM58 introduced
Study Psilocybin-based Medication Treatment
14 Mar 2025 · Texas
SB3005 introduced
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.
13 Mar 2025 · Texas
HB4813 introduced
Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration with respect to those substances.
13 Mar 2025 · West Virginia
HB3343 introduced
Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration
13 Mar 2025 · West Virginia
HB3344 introduced
Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine
12 Mar 2025 · Maine
LD1034 introduced
An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults
11 Mar 2025 · Texas
SB2308 introduced
Relating to the establishment of a consortium to conduct FDA drug development clinical trials with ibogaine
11 Mar 2025 · Vermont
S0106 introduced
An act relating to continuing the Psychedelic Therapy Advisory Working Group
10 Mar 2025 · Nevada
AB378 introduced
Creates the Alternative Therapy Pilot Program. (BDR 40-820)
7 Mar 2025 · Texas
HB4014 introduced
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.
4 Mar 2025 · Texas
HB3717 introduced
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
28 Feb 2025 · Vermont
H0452 introduced
An act relating to decriminalization of psilocybin-containing mushrooms and the establishment of the Psilocybin Therapeutic Consultation Program
27 Feb 2025 · Massachusetts
S1400 introduced
Authorizing a pilot for the use of psychedelics in licensed treatment facilities
27 Feb 2025 · Massachusetts
H1624 introduced
Establishing a task force to study equitable access to psilocybin and other entheogenic plants
27 Feb 2025 · Massachusetts
H1726 introduced
Relative to criminal disposition of limited psilocybin possession offenses
27 Feb 2025 · Massachusetts
H1858 introduced
Relative to removing criminal penalties for limited psilocybin possession
27 Feb 2025 · Massachusetts
H2203 introduced
Establishing a pilot program for access to regulated psilocybin
27 Feb 2025 · Massachusetts
H2506 introduced
Decriminalizing psilocybin as a treatment for PTSD and certain other conditions
27 Feb 2025 · Massachusetts
H2532 introduced
Relative to therapeutic psilocybin treatment centers
27 Feb 2025 · Massachusetts
S1113 introduced
Relative to removing criminal penalties for limited psilocybin possession
26 Feb 2025 · Iowa
HF609 introduced
A bill for an act relating to the use of certain psychoactive substances under the religious freedom restoration Act.
26 Feb 2025 · Iowa
HF620 introduced
A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.)
26 Feb 2025 · Nevada
SJR10 introduced
Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds.
24 Feb 2025 · Connecticut
HB07065 introduced
An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin.
24 Feb 2025 · Iowa
SSB1177 introduced
A bill for an act relating to the controlled substance crystalline polymorph psilocybin.
21 Feb 2025 · California
SB751 introduced
Veterans and Former First Responders Research Pilot Program.
20 Feb 2025 · California
AB1103 introduced
Controlled substances: research.
20 Feb 2025 · New York
S05303 introduced
Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions — Amended and recommitted to Health; still pending, latest action date unconfirmed (low confidence — check).
20 Feb 2025 · Virginia
SB1135 passed legislature
Crystalline polymorph psilocybin; regulations for prescribing, etc.
18 Feb 2025 · Kentucky
SB240 introduced
AN ACT relating to Ibogaine research in the Commonwealth.
14 Feb 2025 · New Mexico
SB410 introduced
Crystalline Polymorph Psilocybin Rescheduling
13 Feb 2025 · Iowa
HF383 introduced
A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (Formerly HF 14.) Vetoed 6-11-25.
12 Feb 2025 · Iowa
HF351 introduced
A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act.
11 Feb 2025 · Georgia
HB382 introduced
Controlled substances; Schedule I; psilocybin; revise a provision
11 Feb 2025 · New York
S04664 introduced
Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders.
7 Feb 2025 · Illinois
SB2184 introduced
USE AND RESEARCH-ENTHEOGENS
7 Feb 2025 · Nebraska
LB72 passed legislature
Change provisions relating to controlled substances schedules under the Uniform Controlled Substances Act
6 Feb 2025 · Illinois
HB2992 introduced
HOPE PILOT PROGRAM
3 Feb 2025 · Kansas
HB2218 introduced
Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.
30 Jan 2025 · New York
A03775 introduced
Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.
30 Jan 2025 · New York
A03845 introduced
Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund.
24 Jan 2025 · Rhode Island
H5186 introduced
Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations.
23 Jan 2025 · Connecticut
HB06380 introduced
An Act Decriminalizing The Possession Of Psilocybin.
22 Jan 2025 · Connecticut
SB00855 introduced
An Act Concerning Funding For The Psychedelic-assisted Therapy Pilot Program.
21 Jan 2025 · Missouri
HB951 introduced
Modifies provisions relating to alternative therapies and treatments, including psilocybin
20 Jan 2025 · Washington
HB1433 introduced
Concerning access to psychedelic substances.
17 Jan 2025 · Connecticut
HB05456 introduced
An Act Allowing The Use Of Psilocybin For Medicinal And Therapeutic Purposes.
17 Jan 2025 · Hawaii
SB1042 introduced
Relating To Mental Health.
15 Jan 2025 · New York
A02142 introduced
Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions — Amended and recommitted to Health; still pending, latest action date unconfirmed (low confidence — check).
14 Jan 2025 · Iowa
HF14 introduced
A bill for an act relating to the controlled substance crystalline polymorph psilocybin.(See HF 383.)
14 Jan 2025 · New Hampshire
HB528 introduced
Amending the penalties for the possession and use of psilocybin for persons 18 years of age or older.
14 Jan 2025 · New York
S01817 introduced
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
13 Jan 2025 · New York
S01801 introduced
Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund.
13 Jan 2025 · Washington
SB5201 introduced
Concerning access to psychedelic substances.
13 Jan 2025 · Washington
SB5204 introduced
Concerning ibogaine-assisted therapy.
10 Jan 2025 · New York
A01522 introduced
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
9 Jan 2025 · Illinois
HB1143 introduced
Illinois CURE Act (an act concerning health) — Still pending as of Oct 21, 2026: re-referred to House Rules Committee on March 27, 2026.
9 Jan 2025 · Missouri
HB829 introduced
Modifies provisions relating to alternative therapies and treatments, including psilocybin
9 Jan 2025 · Nebraska
LB72 introduced
Change provisions relating to controlled substances schedules under the Uniform Controlled Substances Act
8 Jan 2025 · Colorado
HB1063 introduced
FDA-Approved Crystalline Polymorph Psilocybin Use
8 Jan 2025 · Missouri
SB90 introduced
Modifies provisions relating to alternative therapies and treatments, including psilocybin
8 Jan 2025 · New York
A00628 introduced
Legalizes adult possession and use of certain natural plant or fungus-based hallucinogens; grants certain protections for individuals lawfully using such hallucinogens; removes such hallucinogens from the list of schedule I controlled substances; makes related provisions.
8 Jan 2025 · New York
S00495 introduced
Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.
7 Jan 2025 · North Dakota
SB2064 introduced
Relating to the scheduling of controlled substances — Enacted; filed with the Secretary of State on March 26, 2025.
7 Jan 2025 · Virginia
SB1135 introduced
Crystalline polymorph psilocybin; regulations for prescribing, etc.
